MDNA - Medicenna Therapeutics stock slides on launch of units offering

• Medicenna Therapeutics ( NASDAQ: MDNA ) shares fell 6% in Monday's extended session after the immunotherapy company announced the launch of an underwritten public offering of units in the U.S.
• Each unit will be comprised of one common share and one warrant to purchase common shares.
• The offering is expected to be priced in the context of the market, with the final terms to be determined at the time of pricing.
• The company plans to use the net proceeds primarily to fund the clinical development of MDNA11, the pre-clinical development of a BiSKIT candidate, working capital and for general corporate purposes.

For further details see: